Pharmaceutical insights for clinicians

New pharma fact book guides clinicians on rational choice of medicines

By MYLENE C. ORILLO

The Philippine Medical Association recently introduced a new fact book that discusses key issues surrounding the current state of pharmacological interventions.

The fact book entitled, Pharmaceutical Insights for the Well-Informed Clinicians, has been designed to enable healthcare professionals make informed decisions in the selection of medicines.

The fact book reveals the lifecycle of a drug and the many facets surrounding drug development, manufacturing, supply chain, and drug product regulation, among others. It has been developed in alignment with the principles of medical ethics and all other activities related to therapeutic interventions.

Seeking to help physicians, the book includes challenges faced by the pharmaceutical industry in bringing lifesaving medicines to the market and regulatory efforts. It highlights the work of the Philippines Food and Drug Administration (FDA) to ensure that drugs in the market are safe and effective.

“Practicing pharmacovigilance is aimed at improving the care given to patients and protecting their lives. In order to prevent unnecessary suffering by patients and to decrease the financial burden brought about by the adverse events related to medicines, it is essential that all healthcare workers should be the frontliners in advocating pharmacovigilance by reporting all suspected cases especially when the reaction is unusual, potentially serious or clinically significant,” said Dr. Minerva Calimag, PMA president.

A case in point, she said, is a doctor monitoring an adverse drug reaction (ADR) case and submitting a report to the hospital and FDA, keeping in mind that this simple act of pharmacovigilance can improve the practices related to drugs within the hospital and most importantly, can save the life of the patient.

The launch, which was in partnership with Johnson & Johnson (Philippines), Inc (JJPI), was graced by PMA President Dr. Minerva Calimag; Department of Health Assistant Secretary Paulyn Ubial; and Dr. Suzette Lazo, former Philippine FDA director, who discussed important drug regulation updates and understanding the importance of drug development and utilization at the bedside, respectively.

Because of its importance in the clinical practice of the doctors, the fact book will be launched as part of the on-line module of the Philippine Medical Association for their On-line Web-based Learning Partnerships for Medical Advancement (OWL@PMA).

To know more about the fact book, visit www.owlpma.com.

Vital Signs Issue 79 Vol. 4, September 1-30 2015